Vis enkel innførsel

dc.contributor.authorMeling, Siveng
dc.contributor.authorKvalheim, Olav Martineng
dc.contributor.authorArneberg, Reidareng
dc.contributor.authorBårdsen, Kjetileng
dc.contributor.authorHjelle, Anneeng
dc.contributor.authorUlvund, Martha J.eng
dc.date.accessioned2013-12-09T08:47:24Z
dc.date.available2013-12-09T08:47:24Z
dc.date.issued2013-11-14eng
dc.PublishedBMC Research Notes 6(1):466eng
dc.identifier.issn1756-0500en_US
dc.identifier.urihttps://hdl.handle.net/1956/7580
dc.description.abstractBackground: Classical scrapie in sheep is a fatal neurodegenerative disease associated with the conversion PrPC to PrPSc. Much is known about genetic susceptibility, uptake and dissemination of PrPSc in the body, but many aspects of prion diseases are still unknown. Different proteomic techniques have been used during the last decade to investigate differences in protein profiles between affected animals and healthy controls. We have investigated the protein profiles in serum of sheep with scrapie and healthy controls by SELDI-TOF-MS and LC-MS/MS. Latent Variable methods such as Principal Component Analysis, Partial Least Squares-Discriminant Analysis and Target Projection methods were used to describe the MS data. Results: The serum proteomic profiles showed variable differences between the groups both throughout the incubation period and at the clinical end stage of scrapie. At the end stage, the target projection model separated the two groups with a sensitivity of 97.8%, and serum amyloid A was identified as one of the protein peaks that differed significantly between the groups. Conclusions: At the clinical end stage of classical scrapie, ten SELDI peaks significantly discriminated the scrapie group from the healthy controls. During the non-clinical incubation period, individual SELDI peaks were differently expressed between the groups at different time points. Investigations of differences in -omic profiles can contribute to new insights into the underlying disease processes and pathways, and advance our understanding of prion diseases, but comparison and validation across laboratories is difficult and challenging.en_US
dc.language.isoengeng
dc.publisherBioMed Central Ltd.en_US
dc.rightsAttribution CC BYeng
dc.rights.urihttp://creativecommons.org/licenses/by/2.0eng
dc.subjectScrapieeng
dc.subjectSELDI-TOF-MSeng
dc.subjectPCAeng
dc.subjectPLS-DAeng
dc.subjectTarget projectioneng
dc.subjectLC-MS/MSeng
dc.subjectSerum amyloid Aeng
dc.subjectSheepeng
dc.titleInvestigation of serum protein profiles in scrapie infected sheep by means of SELDI-TOF-MS and multivariate data analysisen_US
dc.typePeer reviewed
dc.typeJournal article
dc.date.updated2013-11-25T16:07:31Z
dc.description.versionPeer Reviewed
dc.description.versionpublishedVersionen_US
dc.rights.holderSiv Meling et al.; licensee BioMed Central Ltd.en_US
dc.rights.holderCopyright 2013 Meling et al.; licensee BioMed Central Ltd.en_US
dc.identifier.doihttps://doi.org/10.1186/1756-0500-6-466
dc.identifier.cristin1097691


Tilhørende fil(er)

Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution CC BY
Med mindre annet er angitt, så er denne innførselen lisensiert som Attribution CC BY